Aislinn Antrim is managing editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and received her master’s in communication and media at Rutgers University in 2023.
FDA Approves Treatment for Pollen-Induced Allergic Rhinitis in Children, Adolescents
April 20th 2021The FDA has expanded its approval of short ragweed pollen allergen extract (Ragwitek; ALK) to include treatment for children and adolescents, starting at age 5 years, with short ragweed pollen-induced allergic rhinitis.
Read More
Experts Anticipate Flood of Chronic Health Conditions Due to Interrupted Health Care During Pandemic
April 19th 2021Long-term societal and economic impacts of the COVID-19 pandemic have promoted urgent responses in many sectors, which could lead to real-world efforts to improve prevention of chronic health conditions.
Read More
Direct Oral Anticoagulants Can Minimize IV Treatment in Pediatric Patients
April 15th 2021Pharmacokinetic differences in pediatric patients should be considered when administering direct oral anticoagulants, as should potential administration difficulties when pellets or oral solutions are not available.
Read More
Choice of Blood Pressure Medications Impacts Long-Term Heart Disease Risk in Patients With HIV
April 12th 2021Among patients with HIV who had not been diagnosed with heart disease at the beginning of the study, the risk of developing heart disease, heart failure, or stroke for the first time was 90% higher among those taking beta-blockers.
Read More
New Drugs Show Promise in Triple-Negative, HER2-Positive Breast Cancer
April 8th 2021A session at the Community Oncology Alliance virtual 2021 conference noted that clinical trials have found promising new treatments for patients with breast cancer, offering opportunities for future new approvals and indications.
Read More
Integrating Palliative Care Early in Cancer Diagnosis Improves Quality of Life, May Improve Outcomes
April 8th 2021In patients who received early palliative care, researchers noted a lower percentage of patients with depression, improved quality of life, and, significantly, longer survival.
Read More
Oncology Pharmacists Discuss Pandemic Management, Ongoing Impact for Patients with Cancer
April 8th 2021Panelists at the Community Oncology Alliance (COA) virtual 2021 conference said the impacts of the pandemic on their day-to-day operations were challenging, although they all said they were proud of how their staff handled the rapid changes in spring of 2020.
Read More
Study: Chemotherapy to Treat Glioblastoma May Be More Effective During Morning
April 8th 2021Patients with glioblastoma receiving temozolomide in the morning had an average overall survival of about 17 months, compared to an average overall survival of approximately 13.5 months for those taking the drug in the evening.
Read More
Oncology Pharmacists Are Essential Members of Care Teams to Handle Drug Shortages, Errors
April 6th 2021The oncology space has seen rapid growth in the last decade, with new approvals and indications necessitating expertise in areas such as medication use, safe practices, and reimbursement practices.
Read More